Hui Zeng

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Molecular medicine (Cambridge, Mass.)

Leukemia

Journal of hematology & oncology

Stem cell research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Fangshu Liu, Xiaofan Sun, Suqi Deng, Yingying Wu, Xingcheng Liu, Caiping Wu, Kexiu Huang, Yue Li, Zexuan Dong, Weihao Xiao, Manchun Li, Zhiyang Chen, Zhenyu Ju, Jia Xiao, Juan Du, Hui Zeng
Cxcl10 and Cxcr3 regulate self-renewal and differentiation of hematopoietic stem cells. Stem cell research & therapy 15 (1) (2024)
Fangshu Liu, Xiaofan Sun, Suqi Deng, Yingying Wu, Xingcheng Liu, Caiping Wu, Kexiu Huang, Yue Li, Zexuan Dong, Weihao Xiao, Manchun Li, Zhiyang Chen, Zhenyu Ju, Jia Xiao, Juan Du, Hui Zeng
Cxcl10 and Cxcr3 regulate self-renewal and differentiation of hematopoietic stem cells. Stem cell research & therapy 15 (1) (2024)
Xiaofan Sun, Juan Du, Heng Meng, Fangshu Liu, Nianhui Yang, Suqi Deng, Heng Wan, Dewei Ye, Erfei Song, Hui Zeng
Targeting autophagy with SAR405 alleviates doxorubicin-induced cardiotoxicity. Cell biology and toxicology (2023)
Lei Hua, Nianhui Yang, Yue Li, Kexiu Huang, Xinya Jiang, Fangshu Liu, Zhi Yu, Jie Chen, Jing Lai, Juan Du, Hui Zeng
Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-CHOP pathway. British journal of haematology (2023)
Tianming Zhao, Qiang He, Shurong Xie, Huien Zhan, Cheng Jiang, Shengbin Lin, Fangshu Liu, Cong Wang, Guo Chen, Hui Zeng
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Tianming Zhao, Qiang He, Shurong Xie, Huien Zhan, Cheng Jiang, Shengbin Lin, Fangshu Liu, Cong Wang, Guo Chen, Hui Zeng
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Tianming Zhao, Qiang He, Shurong Xie, Huien Zhan, Cheng Jiang, Shengbin Lin, Fangshu Liu, Cong Wang, Guo Chen, Hui Zeng
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Tianming Zhao, Qiang He, Shurong Xie, Huien Zhan, Cheng Jiang, Shengbin Lin, Fangshu Liu, Cong Wang, Guo Chen, Hui Zeng
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Suqi Deng, Juan Du, Robert Peter Gale, Lu Wang, Huien Zhan, Fangshu Liu, Kexiu Huang, Hao Xu, Hui Zeng
Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia. Leukemia (2023)
Tianming Zhao, Qiang He, Shurong Xie, Huien Zhan, Cheng Jiang, Shengbin Lin, Fangshu Liu, Cong Wang, Guo Chen, Hui Zeng
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Hua Wang, Bi-Bo Fu, Zhi-Jun Wuxiao, Ya-Jun Li, Li Huang, Jie Ma, Zhi-Min Zhai, Jing Guo, Yuan-Bin Wu, Zhen-Shu Xu, Jia Feng, Sheng-Sheng Zhou, Ting-Ting Chen, Xing-Gui Chen, Guo-Wei Li, Ting-Zhi Liu, Hai-Bin Huang, Run-Hui Zheng, Yong-Hua Li, Hong-Fang Tao, Fu-Ming Zi, Fan Wu, Juan Wang, Hui Zeng, Cai-Bo Fu, Robert Peter Gale, Zhong-Jun Xia, Zhi-Wei Liang
A prognostic survival nomogram for persons with extra-nodal natural killer-/T-cell lymphoma. Leukemia 36 (11) (2022)
Cheng Zhou, Juan Du, Liang Zhao, Wei Liu, Tianming Zhao, Hui Liang, Peng Fang, Kaixuan Zhang, Hui Zeng
GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia. Cell death & disease 12 (3) (2021)
Yan Jia, Wei Liu, Hui-En Zhan, Xiao-Ping Yi, Hui Liang, Qi-Li Zheng, Xin-Ya Jiang, Hai-Yan Zhou, Liang Zhao, Xie-Lan Zhao, Hui Zeng
Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia. Journal of hematology & oncology 13 (1) (2020)
Tianming Zhao, Juan Du, Hui Zeng
Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer. Journal of hematology & oncology 13 (1) (2020)

Hui Zeng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hui Zeng